• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性肠系膜缺血死亡率的预测因素:一项系统评价与荟萃分析

Predictors of Mortality in Acute Mesenteric Ischemia: A Systematic Review and Meta-Analysis.

作者信息

Sumbal Ramish, Ali Baig Mirza Mehmood, Sumbal Anusha

机构信息

Dow medical college, Dow University of Health Sciences, Karachi, Pakistan.

Dow medical college, Dow University of Health Sciences, Karachi, Pakistan.

出版信息

J Surg Res. 2022 Jul;275:72-86. doi: 10.1016/j.jss.2022.01.022. Epub 2022 Feb 24.

DOI:10.1016/j.jss.2022.01.022
PMID:35220147
Abstract

INTRODUCTION

To highlight predictors of mortality in acute mesenteric ischemia (AMI) by conducting a meta-analysis of all relevant published studies.

METHODS

PubMed, Cochrane, and Google Scholar were searched from their inception till October 31, 2021. Studies evaluating predictors of mortality were selected. Only those factors were selected for meta-analysis that was reported by at least four studies. Meta-analysis was performed on selected factors using the random-effects model by using Revman 5.3 software.

RESULTS

Fifty-one studies were included evaluating 10,425 patients of AMI. Studies selected had a low risk of bias (Median = 7). Thirty-three factors were evaluated in our review. Age (OR 1.17, 95% CI 1.08-1.27), chronic renal disease (OR 2.47, 95% CI 1.37-4.45), patient dependency (OR 3.01, 95% CI 1.95-4.65), arrhythmias (OR 1.93, 95% CI 1.38-2.69), cardiac failure (OR 2.28, 95% CI 1.57-3.31), hypotension (OR 3.44, 95% CI 1.81-6.54), large bowel involvement (OR 2.98, 95% CI 1.44-6.17), small and large bowel involvement (OR 1.86, 95% CI 1.23-2.81), creatinine (OR 1.67, 95% CI 1.27-2.20), lactate (OR 1.43, 95% CI 1.26-1.62), delay to surgery (OR 2.51, 95% CI 1.58-3.99) and inotropes (OR 3.79, 95% CI 1.47-9.77) were significantly associated with mortality. On the contrary bowel wall thickening (OR 0.53, 95% CI 0.38-0.88), anticoagulation (OR 0.27, 95% CI 0.10-0.74), and revascularization (OR 0.30, 95% CI 0.13-0.69) were significantly associated with survival.

CONCLUSIONS

In conclusion, Age, chronic renal disease, diabetes, patient dependency, arrhythmias, cardiac failure, hypotension, large bowel involvement, small & large bowel involvement, creatinine, lactate, delay to surgery, and inotropes were significantly associated with mortality while anticoagulants, revascularization and bowel thickening on CT was associated with decreased mortality.

摘要

引言

通过对所有相关已发表研究进行荟萃分析,以突出急性肠系膜缺血(AMI)患者死亡率的预测因素。

方法

检索了PubMed、Cochrane和谷歌学术数据库,检索时间从建库至2021年10月31日。选取评估死亡率预测因素的研究。仅选择至少四项研究报告的因素进行荟萃分析。使用Revman 5.3软件,对选定因素采用随机效应模型进行荟萃分析。

结果

纳入51项研究,共评估了10425例AMI患者。所选研究的偏倚风险较低(中位数 = 7)。我们的综述中评估了33个因素。年龄(比值比[OR]1.17,95%置信区间[CI]1.08 - 1.27)、慢性肾病(OR 2.47,95% CI 1.37 - 4.45)、患者依赖程度(OR 3.01,95% CI 1.95 - 4.65)、心律失常(OR 1.93,95% CI 1.38 - 2.69)、心力衰竭(OR 2.28,95% CI 1.57 - 3.31)、低血压(OR 3.44,95% CI 1.81 - 6.54)、大肠受累(OR 2.98,95% CI 1.44 - 6.17)、小肠和大肠均受累(OR 1.86,95% CI 1.23 - 2.81)、肌酐(OR 1.67,95% CI 1.27 - 2.20)、乳酸(OR 1.43,95% CI 1.26 - 1.62)、手术延迟(OR 2.51,95% CI 1.58 - 3.99)和血管活性药物(OR 3.79,95% CI 1.47 - 9.77)与死亡率显著相关。相反,肠壁增厚(OR 0.53,95% CI 0.38 - 0.88)、抗凝治疗(OR 0.27,95% CI 0.10 - 0.74)和血管再通(OR 0.30,95% CI 0.13 - 0.69)与生存率显著相关。

结论

总之,年龄、慢性肾病、糖尿病患者依赖程度、心律失常、心力衰竭、低血压、大肠受累、小肠和大肠均受累、肌酐、乳酸、手术延迟和血管活性药物与死亡率显著相关,而抗凝治疗、血管再通以及CT显示的肠壁增厚与死亡率降低相关。

相似文献

1
Predictors of Mortality in Acute Mesenteric Ischemia: A Systematic Review and Meta-Analysis.急性肠系膜缺血死亡率的预测因素:一项系统评价与荟萃分析
J Surg Res. 2022 Jul;275:72-86. doi: 10.1016/j.jss.2022.01.022. Epub 2022 Feb 24.
2
Perioperative beta-blockers for preventing surgery-related mortality and morbidity.围手术期使用β受体阻滞剂预防手术相关的死亡率和发病率。
Cochrane Database Syst Rev. 2018 Mar 13;3(3):CD004476. doi: 10.1002/14651858.CD004476.pub3.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Beta-blockers in patients without heart failure after myocardial infarction.心肌梗死后无心力衰竭的患者使用β受体阻滞剂。
Cochrane Database Syst Rev. 2021 Nov 5;11(11):CD012565. doi: 10.1002/14651858.CD012565.pub2.
5
Radiological predictive factors of transmural intestinal necrosis in acute mesenteric ischemia: systematic review and meta-analysis.急性肠系膜缺血中透壁性肠坏死的放射学预测因素:系统评价和荟萃分析。
Eur Radiol. 2023 Apr;33(4):2792-2799. doi: 10.1007/s00330-022-09258-5. Epub 2022 Nov 30.
6
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery.非心脏手术老年患者术后认知结局:静脉麻醉维持与吸入麻醉维持的比较
Cochrane Database Syst Rev. 2018 Aug 21;8(8):CD012317. doi: 10.1002/14651858.CD012317.pub2.
8
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块型银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2022 May 23;5(5):CD011535. doi: 10.1002/14651858.CD011535.pub5.
10
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.

引用本文的文献

1
Tricky acute mesenteric ischemia: what can we do?棘手的急性肠系膜缺血:我们能做些什么?
Gastroenterol Rep (Oxf). 2025 Jul 7;13:goaf067. doi: 10.1093/gastro/goaf067. eCollection 2025.
2
Anticoagulation management and outcomes in critically ill patients with acute mesenteric ischemia: an international study.危重症急性肠系膜缺血患者的抗凝管理与结局:一项国际研究
Intensive Care Med. 2025 Jun 16. doi: 10.1007/s00134-025-07980-4.
3
Diagnostic Performance of Clinical and Routine Laboratory Data in Acute Mesenteric Arterial Occlusion-An International Multicenter Study.
临床及常规实验室数据在急性肠系膜动脉闭塞诊断中的性能——一项国际多中心研究
Diagnostics (Basel). 2024 Nov 30;14(23):2705. doi: 10.3390/diagnostics14232705.
4
Revascularization Strategies for Acute and Chronic Mesenteric Ischemia: A Narrative Review.急性和慢性肠系膜缺血的血运重建策略:一篇叙述性综述
J Clin Med. 2024 Feb 21;13(5):1217. doi: 10.3390/jcm13051217.
5
Development of a nomogram to predict 30-day mortality of sepsis patients with gastrointestinal bleeding: An analysis of the MIMIC-IV database.用于预测伴有胃肠道出血的脓毒症患者30天死亡率的列线图的开发:MIMIC-IV数据库分析
Heliyon. 2024 Feb 17;10(4):e26185. doi: 10.1016/j.heliyon.2024.e26185. eCollection 2024 Feb 29.
6
Identifying survival protective factors for chronic dialysis patients with surgically confirmed acute mesenteric ischemia.确定经手术确诊的急性肠系膜缺血的慢性透析患者的生存保护因素。
World J Gastrointest Surg. 2022 Aug 27;14(8):809-820. doi: 10.4240/wjgs.v14.i8.809.